{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:17:47Z","timestamp":1759796267405,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.prp.2022.153989","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T11:12:24Z","timestamp":1655464344000},"page":"153989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"236","author":[{"given":"Jia-Ning","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Yang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Ye","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Fei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prp.2022.153989_bib1","doi-asserted-by":"crossref","DOI":"10.1177\/1073274817729245","article-title":"Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"24","author":"Massarweh","year":"2017","journal-title":"Cancer Control"},{"issue":"5","key":"10.1016\/j.prp.2022.153989_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.21037\/cco.2016.10.02","article-title":"Combined intrahepatic cholangiocarcinoma and hepatocellular carcinoma","volume":"5","author":"Connell","year":"2016","journal-title":"Chin. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2022.153989_bib3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2015.09.008","article-title":"Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management","volume":"379","author":"Zhang","year":"2016","journal-title":"Cancer Lett."},{"issue":"22","key":"10.1016\/j.prp.2022.153989_bib4","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1002\/cncr.28312","article-title":"Multidisciplinary approaches to intrahepatic cholangiocarcinoma","volume":"119","author":"Maithel","year":"2013","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.prp.2022.153989_bib5","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181277","article-title":"TRIM59 knockdown inhibits cell proliferation by down-regulating the Wnt\/\u03b2-catenin signaling pathway in neuroblastoma","volume":"39","author":"Chen","year":"2019","journal-title":"Biosci. Rep."},{"issue":"19","key":"10.1016\/j.prp.2022.153989_bib6","doi-asserted-by":"crossref","first-page":"8623","DOI":"10.18632\/aging.102351","article-title":"TRIM59 loss in M2 macrophages promotes melanoma migration and invasion by upregulating MMP-9 and Madcam1","volume":"11","author":"Tian","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"16","key":"10.1016\/j.prp.2022.153989_bib7","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1073\/pnas.90.16.7451","article-title":"Striatal Fos expression is indicative of dopamine D1\/D2 synergism and receptor supersensitivity","volume":"90","author":"LaHoste","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.prp.2022.153989_bib8","first-page":"674","article-title":"TRIM59 promotes cell proliferation, migration and invasion in human hepatocellular carcinoma cells","volume":"72","author":"Sun","year":"2017","journal-title":"Pharmazie"},{"issue":"2","key":"10.1016\/j.prp.2022.153989_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/13651820801992641","article-title":"Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma","volume":"10","author":"Khan","year":"2008","journal-title":"HPB (Oxf.)"},{"issue":"1","key":"10.1016\/j.prp.2022.153989_bib10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejso.2014.09.007","article-title":"Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis","volume":"41","author":"Al-Adra","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2022.153989_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3892\/mco.2021.2314","article-title":"Stereotactic radiotherapy in intrahepatic cholangiocarcinoma: a systematic review","volume":"15","author":"Bisello","year":"2021","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.prp.2022.153989_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy","volume":"93","author":"P\u00e9rez-Herrero","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"10.1016\/j.prp.2022.153989_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4161\/bioe.24666","article-title":"Production of recombinant immunotherapeutics for anticancer treatment: the role of bioengineering","volume":"4","author":"Pranchevicius","year":"2013","journal-title":"Bioengineered"},{"issue":"11","key":"10.1016\/j.prp.2022.153989_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11864-019-0682-x","article-title":"Targeted therapies for triple-negative breast cancer","volume":"20","author":"Lyons","year":"2019","journal-title":"Curr. Treat. Options Oncol."},{"issue":"1","key":"10.1016\/j.prp.2022.153989_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/21655979.2021.1976894","article-title":"Long non-coding RNA DCST1-AS1\/hsa-miR-582-5p\/HMGB1 axis regulates colorectal cancer progression","volume":"13","author":"Huang","year":"2022","journal-title":"Bioengineered"},{"issue":"3","key":"10.1016\/j.prp.2022.153989_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1634\/theoncologist.2013-0352","article-title":"New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing","volume":"19","author":"Ross","year":"2014","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.prp.2022.153989_bib17","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/j.gastro.2014.07.021","article-title":"TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53","volume":"147","author":"Zhou","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.prp.2022.153989_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3892\/or.2017.5654","article-title":"TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K\/AKT pathway","volume":"38","author":"Sun","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2022.153989_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2019.12.030","article-title":"TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B","volume":"473","author":"Ying","year":"2020","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.prp.2022.153989_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142596","article-title":"TRIM59 promotes the proliferation and migration of non-small cell lung cancer cells by upregulating cell cycle related proteins","volume":"10","author":"Zhan","year":"2015","journal-title":"PLoS One"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822002333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822002333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:53:30Z","timestamp":1759733610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822002333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":20,"alternative-id":["S0344033822002333"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.153989","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.153989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153989"}}